Several topical agents have been used for treating Pityriasis versicolor. But the main problem is recurrence. In this study 82 patients with recurrent and/or extensive from of infection were treated with oral Ketoconazole. 200 mg once daily for a maximum of 4 weeks. Seventeen patients have been infected for the first time and sixty five for the several times. The duration of disease in most cases (35.4%) were between 1-3 years. Out of 82 studied patients only 60 cases were referred for follow up. The clinical and mycological cure were seen in 54 cases (90%) after 15 days therapy. In other 6 patients after 15 days the lesions have not cured completely so the treatment was continued for other 2 weeks, but after that, only one of them referred...
AIM: Compare itraconazole alone, fluconazole combined with ketoconazole and ketoconazole in the trea...
Ketoconazole was administered orally in daily doses of 200 mg to 70 patients with ony-chomycosis. Co...
Four patients with chronic mucocutaneous candidosis from early infancy were treated successfully wit...
Introduction: Both topical and systemic ketoconazole are reported to be effective against pityriasis...
Introduction: Both topical and systemic ketoconazole are reported to be effective against pityriasis...
Treatment with oral antifungals is usually preferred when pityriasis versicolor (PV) affects large b...
Objectives: This study was to evaluate the clinical efficacy of 1% topical luliconazole versus 2% to...
Background: Pityriasis versicolor (PV), also known as tinea versicolor, is caused by Malassezia spec...
The objective of this research was to evaluate the efficacy of a new antifungal imidazole, dapaconaz...
ABSlRACf: Multiple open and double-blind studieshaveconfirmedthe efficacy of ketoeonazole in the tre...
BACKGROUND Pityriasis versicolor is one of the most common and recurring superficial fungal infecti...
Experimentação terapêutico-laboratorial com o Ketoconazol na Pitiríase Versicolor, obtendo os seguin...
Background& Objectives: Pityriasis Versicolor (PV) is a chronic cutaneous fungal infection cause...
This study was designed to compare the therapeutic effects of topical clotrimazole and systemic fluc...
Ketoconazole, a new imidazole-derivative antifungal agent, has been studied in sixteen patients with...
AIM: Compare itraconazole alone, fluconazole combined with ketoconazole and ketoconazole in the trea...
Ketoconazole was administered orally in daily doses of 200 mg to 70 patients with ony-chomycosis. Co...
Four patients with chronic mucocutaneous candidosis from early infancy were treated successfully wit...
Introduction: Both topical and systemic ketoconazole are reported to be effective against pityriasis...
Introduction: Both topical and systemic ketoconazole are reported to be effective against pityriasis...
Treatment with oral antifungals is usually preferred when pityriasis versicolor (PV) affects large b...
Objectives: This study was to evaluate the clinical efficacy of 1% topical luliconazole versus 2% to...
Background: Pityriasis versicolor (PV), also known as tinea versicolor, is caused by Malassezia spec...
The objective of this research was to evaluate the efficacy of a new antifungal imidazole, dapaconaz...
ABSlRACf: Multiple open and double-blind studieshaveconfirmedthe efficacy of ketoeonazole in the tre...
BACKGROUND Pityriasis versicolor is one of the most common and recurring superficial fungal infecti...
Experimentação terapêutico-laboratorial com o Ketoconazol na Pitiríase Versicolor, obtendo os seguin...
Background& Objectives: Pityriasis Versicolor (PV) is a chronic cutaneous fungal infection cause...
This study was designed to compare the therapeutic effects of topical clotrimazole and systemic fluc...
Ketoconazole, a new imidazole-derivative antifungal agent, has been studied in sixteen patients with...
AIM: Compare itraconazole alone, fluconazole combined with ketoconazole and ketoconazole in the trea...
Ketoconazole was administered orally in daily doses of 200 mg to 70 patients with ony-chomycosis. Co...
Four patients with chronic mucocutaneous candidosis from early infancy were treated successfully wit...